News

Jubilant Pharmova has postponed the meeting of the Board of Directors which was scheduled to be held on 7 August 2026. The meeting will now be held on 10 August 2026.

Jubilant Pharmova will hold a meeting of the Board of Directors of the Company on 7 August 2026.

Jubilant Pharmova announced that the 48th Annual General Meeting(AGM) of the company will be held on 26 August 2026.

Jubilant Pharmova announced that United States Food and Drug Administration (USFDA) has concluded an inspection of Jubilant HollisterStier LLC (JHS)`s contract manufacturing facility located in Spokane, WA. U.S.A on 17 June 2026. The USFDA had issued eight (8) observations, none of which are related to sterility assurance concerns.Jubilant HollisterStier LLC is a subsidiary of Jubilant Pharma Holding Inc., which is a subsidiary of Jubilant Pharma, Singapore, a wholly owned subsidiary of the company.

Jubilant Pharmova announced that the Board of Directors of the Company at its meeting held on 22 May 2026, inter alia, have recommended the final dividend of Rs 5 per equity Share (i.e. 500%) , subject to the approval of the shareholders.